510(k) Report

510(k) · Cleared

Cleared

Tranquil Tri-Bte

K061459510(k) SpecialCleared Jun 30, 200635-day reviewClass II21 CFR 874.3400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

General Hearing Instruments, Inc. · KLW Masker, Tinnitus

Cleared on Jun 30, 2006 after a 35-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 1 later device descends from it.

Decided
Jun 30, 2006
Review
35 days
Class
Class II
Product code
KLW
Recalls
None
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2023: 1 descendant cleared20052010201520202025
  1. This deviceK061459 Tranquil Tri-BteGeneral Hearing Instruments, Inc. · 2006
  2. Descendant · cites it directly · 0 of its ownK223694 Tinearity G1 (6103); Tinearity G1 Adapters x3 (6042)Duearity AB · 2023

Most influential descendants

Showing 1 of 1 · See all
  • K223694Tinearity G1 (6103); Tinearity G1 Adapters x3 (6042)Duearity AB · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K061459Tranquil Tri-BteGeneral Hearing Instruments, Inc.2006—
+1K223694Tinearity G1 (6103); Tinearity G1 Adapters x3 (6042)Duearity AB2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of K061459, 2006–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KLW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KLW device

  1. #1 K260413 Levo Gen 2 Tinnitus Therapy Systemscore 11.8 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K223694Tinearity G1 (6103); Tinearity G1 Adapters x3 (6042)Duearity AB20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K223694 (Duearity AB, 2023) has gone furthest, with 0 descendants of its own.

How does its category compare?

All KLW devices

KLW Masker, Tinnitus: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KLW

1in 2024

2007: 22008: 22009: 22010: 12011: 42012: 12013: 42014: 42015: 42016: 32017: 22018: 22020: 22023: 32024: 12026 (partial year): 2
2007high 4 (2011) · low 0 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KLW

261in 2023

2011: 58 days median2013: 150 days median2014: 164 days median2015: 107 days median2016: 114 days median2023: 261 days median
2007high 261 (2023) · low 58 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KLW

No recall names KLW since 2007.

Adverse event reports per year · KLW

4in 2015

2007: 12009: 12010: 12011: 12012: 12015: 4
2007high 4 (2015) · low 0 (2008)2025

MAUDE reports naming product code KLW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—01
20082—00
20092—01
20101—01
201145801
20121—01
2013415000
2014416400
2015410704
2016311400
20172—00
20182—00
20190—00
20202—00
20210—00
20220—00
2023326100
20241—00
20250—00
20262—0—

What is it indicated for?

The Tranquil TRI-BTE is for use in sound therapy for tinnitus retraining therapy, masking, or other recognized forms of tinnitus treatment. Sound therapy should be used in concert with counseling from a physician, an audiologist or other qualified tinnitus specialists.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K061459: Tranquil Tri-Bte.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K061459

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026